Dallas, TX6 Active Studies

Leukemia Clinical Trials in Dallas, TX

Find 6 actively recruiting leukemia clinical trials in Dallas, TX. Connect with local research sites and explore new treatment options.

6
Active Trials
5
Sponsors
868
Enrolling

Recruiting Leukemia Studies in Dallas

RecruitingDallas, TXNCT06406114

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

Cephalosporin antibiotics are commonly used but can result in allergic reactions and anaphylaxis. There is no clear diagnostic approach for cephalosporin-allergic patients, and guidance for the use of...

300 participants
Massachusetts General Hospital
View Study Details
RecruitingDallas, TXNCT05853575

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

This study will evaluate the efficacy of two dosing regimens of adagrasib (600 mg BID versus 400 mg BID) in patients with NSCLC with KRAS G12C mutation....

200 participants
Mirati Therapeutics Inc.
View Study Details
RecruitingDallas, TXNCT04588922

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies

SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. In this study the safety, tolerability, and antitumor activity of single agent SLS009 are assessed in two dose escalation grou...

160 participants
Sellas Life Sciences Group
View Study Details
RecruitingDallas, TXNCT04835584

KRT-232 and TKI Study in Chronic Myeloid Leukemia

This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with Ph+ Chronic Myeloid Leukemia (CML) who have relapsed or are refractory or intolerant to ...

109 participants
Kartos Therapeutics, Inc.
View Study Details
RecruitingDallas, TXNCT04358393

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

This is a two Part study in patients with relapsed/refractory acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), or high risk myelodysplastic syndrome (MDS) that will initially eval...

69 participants
Ascentage Pharma Group Inc.
View Study Details
RecruitingDallas, TXNCT06943534

Omalizumab Weight-Based Dosing Efficacy Trial

This research is being conducted to assess the safety and effectiveness of increased dosing of Omalizumab for food allergies....

30 participants
Massachusetts General Hospital
View Study Details

About Leukemia Clinical Trials in Dallas

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 6 leukemia clinical trials recruiting participants in Dallas, TX. These studies are seeking a combined 868 participants. Research is being sponsored by Massachusetts General Hospital, Mirati Therapeutics Inc., Sellas Life Sciences Group and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Dallas — FAQ

Are there leukemia clinical trials in Dallas?

Yes, there are 6 leukemia clinical trials currently recruiting in Dallas, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Dallas?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.

Are clinical trials in Dallas free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 6 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov